MA, MB BChir, MD, FRCP, FRCPEdin, FRCPsych
Professor of Psychological Medicine
- Fellow of Saint Cross College, Oxford.
- Honorary Consultant in Psychological Medicine and Trust Lead in Psychological Medicine at Oxford University Hospitals NHS Foundation Trust and advisor to Oxford Health NHS Foundation Trust.
- Honorary Professor, University of Edinburgh.
- NIHR Senior Investigator
Psychiatric aspects of medical illness and treatment
My research aims to understand the psychiatric aspects of medical illnesses and their treatments, to develop novel interventions for these that are integrated with medical care and to evaluate these in rigorous clinical trials.
My current interests are in developing integrated medical-psychiatric treatments and services especially for people with depression that is comorbid with medical conditions such as cancer and for elderly medical inpatients.
I am a Fellow of the Royal Colleges of Physicians of London and Edinburgh and of the UK Royal College of Psychiatrists.
I serve as Vice-President of the Academy of Consultation-Liaison Psychiatry (AC-LP) in the USA and as a Vice-President of the European Association of Psychosomatic Medicine (EAPM). I am theme lead for medical-psychiatric multi-morbidity in the Oxford NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) and a named investigator in both Oxford Biomedical Research Centres (BRCs)
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): A randomised trial
White PD. et al, (2011), The Lancet, 377, 823 - 836
Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial.
Sharpe M. et al, (2014), Lancet, 384, 1099 - 1108
The prevalence of depression in general hospital inpatients: a systematic review and meta-analysis of interview-based studies.
Walker J. et al, (2018), Psychol Med, 1 - 14
Tutorial: The practical application of longitudinal structural equation mediation models in clinical trials.
Goldsmith KA. et al, (2018), Psychol Methods, 23, 191 - 207
Measurement error, time lag, unmeasured confounding: Considerations for longitudinal estimation of the effect of a mediator in randomised clinical trials.
Goldsmith KA. et al, (2018), Stat Methods Med Res, 27, 1615 - 1633
What about treatment of smoking to improve survival and reduce depression? - Authors' reply.
Sharpe M., (2018), Lancet Psychiatry, 5, 464 - 465